Molecular Biomarkers and Machine Learning in Oral Cancer: A Systematic Review and Meta‐Analysis
Oral Diseases · 2026
DOI: 10.1111/odi.70121 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Oral Diseases, 2026. Verfasst von Carlos M Ardila und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai…. Hauptthemen laut MEDLINE: Mouth Neoplasms, Machine Learning, Biomarkers, Tumor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Objective
This systematic review and meta‐analysis aimed to synthesize diagnostic and prognostic performance metrics of machine learning (ML)‐based biomarker models in oral squamous cell carcinoma (OSCC) and to integrate biological insights through a functional metasynthesis.
Methods
Following PRISMA 2020 guidelines, a comprehensive search was conducted up to July 2025. Eligible studies applied ML algorithms to molecular or imaging biomarkers from OSCC patients. Data synthesis incorporated meta‐analysis when endpoints and designs were sufficiently comparable; otherwise, study‐level results were summarized narratively.
Results
Twenty‐five studies encompassing 4408 patients were included. Diagnostic performance was strongest for salivary DNA methylation (AUC up to 1.00), metabolomics (AUC ≈0.92), and FTIR imaging (AUC ≈0.91), while autoantibody and microbiome models showed more variable accuracy. Prognostic models based on immune‐feature signatures outperformed conventional scores, while multimodal approaches integrating imaging and metabolomics retained strong performance under external validation. Models based on pathomics and MRI radiomics also achieved clinically meaningful accuracy across independent cohorts. Functional metasynthesis revealed convergent biological processes—metabolic reprogramming, immune–inflammatory remodeling, microbiome dysbiosis, and epithelial/extracellular matrix disruption—that underpin predictive accuracy.
Conclusion
ML models leveraging molecular and imaging biomarkers show strong potential to improve OSCC diagnosis, risk stratification, and prognosis, particularly through multimodal integration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
- Biomedical Stomatology Research Group, Basic Sciences Department, Faculty of Dentistry, Universidad de Antioquia (UdeA), Medellín, Colombia.
- Faculty of Dentistry, Institución Universitaria Visión de las Américas, Medellín, Colombia.
ORCID-Profile: Carlos M Ardila
Zitieren
APA
Ardila, C. M., Vivares-Builes, A. M., & Pineda-Vélez, E. (2026). Molecular Biomarkers and Machine Learning in Oral Cancer: A Systematic Review and Meta‐Analysis. Oral Diseases. https://doi.org/10.1111/odi.70121
Vancouver
Ardila CM, Vivares-Builes AM, Pineda-Vélez E. Molecular Biomarkers and Machine Learning in Oral Cancer: A Systematic Review and Meta‐Analysis. Oral Diseases. 2026. doi:10.1111/odi.70121
BibTeX
@article{Ardila2026,
author = {Ardila, Carlos M and Vivares-Builes, Anny Marcela and Pineda-Vélez, Eliana},
title = {Molecular Biomarkers and Machine Learning in Oral Cancer: A Systematic Review and Meta‐Analysis},
journal = {Oral Diseases},
year = {2026},
doi = {10.1111/odi.70121}
}
EUVIMED